Association between non-enzymatic glycation, resorption, and microdamage in human tibial cortices
详细信息    查看全文
  • 作者:A. Ural (1)
    C. Janeiro (2)
    L. Karim (2) (3)
    T. Diab (2)
    D. Vashishth (2)

    1. Department of Mechanical Engineering
    ; Villanova University ; 800 Lancaster Avenue ; Villanova ; PA ; 19085 ; USA
    2. Department of Biomedical Engineering
    ; Center for Biotechnology and Interdisciplinary Studies ; Rensselaer Polytechnic Institute ; Troy ; NY ; 12180 ; USA
    3. Center for Advanced Orthopaedic Studies
    ; Beth Israel Deaconess Medical Center ; Department of Orthopedic Surgery ; Harvard Medical School ; 330 Brookline Avenue ; RN-122 ; Boston ; MA ; 02215 ; USA
  • 关键词:Advanced glycation end ; products ; Bone resorption ; Cortical bone ; Microdamage ; Non ; enzymatic glycation
  • 刊名:Osteoporosis International
  • 出版年:2015
  • 出版时间:March 2015
  • 年:2015
  • 卷:26
  • 期:3
  • 页码:865-873
  • 全文大小:650 KB
  • 参考文献:1. Seeman E, Delmas PD (2006) Bone quality鈥攖he material and structural basis of bone strength and fragility. N Engl J Med 354(21):2250鈥?261 CrossRef
    2. Hui SL, Slemenda CW, Johnston CC Jr (1988) Age and bone mass as predictors of fracture in a prospective study. J Clin Investig 81(6):1804鈥?809 CrossRef
    3. Vashishth D (2005) Age-dependent biomechanical modifications in bone. Crit Rev Eukaryot Gene Expr 15(4):343鈥?58 CrossRef
    4. Vashishth D, Gibson GJ, Khoury JI, Schaffler MB, Kimura J, Fyhrie DP (2001) Influence of nonenzymatic glycation on biomechanical properties of cortical bone. Bone 28(2):195鈥?01 8756-3282(00)00434-8" target="_blank" title="It opens in new window">CrossRef
    5. Wang X, Shen X, Li X, Mauli Agrawal C (2002) Age-related changes in the collagen network and toughness of bone. Bone 31(1):1鈥? 8756-3282(01)00697-4" target="_blank" title="It opens in new window">CrossRef
    6. McCarthy AD, Etcheverry SB, Cortizo AM (1999) Advanced glycation endproduct-specific receptors in rat and mouse osteoblast-like cells: Regulation with stages of differentiation. Acta Diabetol 36(1):45鈥?2 CrossRef
    7. Dong XN, Qin A, Xu J, Wang X (2011) In situ accumulation of advanced glycation endproducts (AGEs) in bone matrix and its correlation with osteoclastic bone resorption. Bone 49(2):174鈥?83 CrossRef
    8. Miyata T, Notoya K, Yoshida K, Horie K, Maeda K, Kurokawa K, Taketomi S (1997) Advanced glycation end products enhance osteoclast-induced bone resorption in cultured mouse unfractionated bone cells and in rats implanted subcutaneously with devitalized bone particles. J Am Soc Nephrol 8(2):260鈥?70
    9. Valcourt U, Merle B, Gineyts E, Viguet-Carrin S, Delmas PD, Garnero P (2007) Non-enzymatic glycation of bone collagen modifies osteoclastic activity and differentiation. J Biol Chem 282(8):5691鈥?703 CrossRef
    10. Tang SY, Vashishth D (2010) Non-enzymatic glycation alters microdamage formation in human cancellous bone. Bone 46(1):148鈥?54 CrossRef
    11. Tang SY, Zeenath U, Vashishth D (2007) Effects of non-enzymatic glycation on cancellous bone fragility. Bone 40(4):1144鈥?151 CrossRef
    12. Bentolila V, Boyce TM, Fyhrie DP, Drumb R, Skerry TM, Schaffler MB (1998) Intracortical remodeling in adult rat long bones after fatigue loading. Bone 23(3):275鈥?81 8756-3282(98)00104-5" target="_blank" title="It opens in new window">CrossRef
    13. Herman BC, Cardoso L, Majeska RJ, Jepsen KJ, Schaffler MB (2010) Activation of bone remodeling after fatigue: Differential response to linear microcracks and diffuse damage. Bone 47(4):766鈥?72 CrossRef
    14. Mashiba T, Hirano T, Turner CH, Forwood MR, Johnston CC, Burr DB (2000) Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib. J Bone Miner Res 15(4):613鈥?20 CrossRef
    15. Diab T, Vashishth D (2007) Morphology, localization and accumulation of in vivo microdamage in human cortical bone. Bone 40(3):612鈥?18 CrossRef
    16. Poundarik AA, Diab T, Sroga GE, Ural A, Boskey AL, Gundberg CM, Vashishth D (2012) Dilatational band formation in bone. Proc Natl Acad Sci 109(47):19178鈥?9183 CrossRef
    17. Karim L, Vashishth D (2012) Heterogeneous glycation of cancellous bone and its association with bone quality and fragility. PLoS One 7(4):e35047 CrossRef
    18. Gross J (1958) Studies on the formation of collagen. I. Properties and fractionation of neutral salt extracts of normal guinea pig connective tissue. J Exp Med 107(2):247鈥?63 84/jem.107.2.247" target="_blank" title="It opens in new window">CrossRef
    19. Burr DB, Stafford T (1990) Validity of the bulk-staining technique to separate artifactual from in vivo bone microdamage. Clin Orthop Relat Res 260:305鈥?08
    20. Boyce TM, Fyhrie DP, Glotkowski MC, Radin EL, Schaffler MB (1998) Damage type and strain mode associations in human compact bone bending fatigue. J Orthop Res 16(3):322鈥?29 8" target="_blank" title="It opens in new window">CrossRef
    21. Tang S, Allen M, Phipps R, Burr D, Vashishth D (2009) Changes in non-enzymatic glycation and its association with altered mechanical properties following 1-year treatment with risedronate or alendronate. Osteoporos Int 20(6):887鈥?94 8-008-0754-4" target="_blank" title="It opens in new window">CrossRef
    22. Yamagishi S-i (2011) Role of Advanced Glycation End Products (AGEs) in osteoporosis in diabetes. Curr Drug Targets 12(14):2096鈥?102 8945011798829456" target="_blank" title="It opens in new window">CrossRef
    23. Semba RD, Nicklett EJ, Ferrucci L (2010) Does accumulation of advanced glycation end products contribute to the aging phenotype? J Gerontol A: Biol Med Sci 65A(9):963鈥?75 CrossRef
    24. Weinberg E, Maymon T, Weinreb M (2014) AGEs induce caspase-mediated apoptosis of rat BMSCs via TNF伪 production and oxidative stress. J Mol Endocrinol 52(1):67鈥?6
    25. Hein GE (2006) Glycation endproducts in osteoporosis鈥擨s there a pathophysiologic importance? Clin Chim Acta 371(1鈥?):32鈥?6 CrossRef
    26. Saito M, Marumo K, Soshi S, Kida Y, Ushiku C, Shinohara A (2010) Raloxifene ameliorates detrimental enzymatic and nonenzymatic collagen cross-links and bone strength in rabbits with hyperhomocysteinemia. Osteoporos Int 21(4):655鈥?66 8-009-0980-4" target="_blank" title="It opens in new window">CrossRef
    27. Hein G, Weiss C, Lehmann G, Niwa T, Stein G, Franke S (2006) Advanced glycation end product modification of bone proteins and bone remodelling: Hypothesis and preliminary immunohistochemical findings. Ann Rheum Dis 65(1):101鈥?04 8" target="_blank" title="It opens in new window">CrossRef
    28. Hein G, Wiegand R, Lehmann G, Stein G, Franke S (2003) Advanced glycation end-products pentosidine and N系-carboxymethyllysine are elevated in serum of patients with osteoporosis. Rheumatology 42(10):1242鈥?246 CrossRef
    29. Franke S, Siggelkow H, Wolf G, Hein G (2007) Advanced glycation endproducts influence the mRNA expression of RAGE, RANKL and various osteoblastic genes in human osteoblasts. Arch Physiol Biochem 113(3):154鈥?61 80/13813450701602523" target="_blank" title="It opens in new window">CrossRef
    30. Ding K-H, Wang Z-Z, Hamrick MW, Deng Z-B, Zhou L, Kang B, Yan S-L, She J-X, Stern DM, Isales CM, Mi Q-S (2006) Disordered osteoclast formation in RAGE-deficient mouse establishes an essential role for RAGE in diabetes related bone loss. Biochem Biophys Res Commun 340(4):1091鈥?097 CrossRef
    31. Fatayerji D, Eastell R (1999) Age-related changes in bone turnover in men. J Bone Miner Res 14(7):1203鈥?210 CrossRef
    32. Minisola S, Dionisi S, Pacitti MT, Paglia F, Carnevale V, Scillitani A, Mazzaferro S, De Geronimo S, Pepe J, D鈥橢rasmo E, Romagnoli E (2002) Gender differences in serum markers of bone resorption in healthy subjects and patients with disorders affecting bone. Osteoporos Int 13(2):171鈥?75 80200009" target="_blank" title="It opens in new window">CrossRef
    33. Rehman MTA, Hoyland JA, Denton J, Freemont AJ (1994) Age related histomorphometric changes in bone in normal British men and women. J Clin Pathol 47(6):529鈥?34 CrossRef
    34. Wishart JM, Need AO, Horowitz M, Morris HA, Nordin BEC (1995) Effect of age on bone density and bone turnover in men. Clin Endocrinol 42(2):141鈥?46 854.x" target="_blank" title="It opens in new window">CrossRef
    35. Martin RB, Pickett JC, Zinaich S (1980) Studies of skeletal remodeling in aging men. Clin Orthop Relat Res 149:268鈥?82
    36. Cooper DML, Thomas CDL, Clement JG, Hallgr铆msson B (2006) Three-dimensional microcomputed tomography imaging of basic multicellular unit-related resorption spaces in human cortical bone. Anat Rec A: Discov Mol Cell Evol Biol 288A(7):806鈥?16 CrossRef
    37. Bernhard A, Milovanovic P, Zimmermann EA, Hahn M, Djonic D, Krause M, Breer S, P眉schel K, Djuric M, Amling M, Busse B (2013) Micro-morphological properties of osteons reveal changes in cortical bone stability during aging, osteoporosis, and bisphosphonate treatment in women. Osteoporos Int 24(10):2671鈥?680 8-013-2374-x" target="_blank" title="It opens in new window">CrossRef
    38. Ural A, Vashishth D (2006) Interactions between microstructural and geometrical adaptation in human cortical bone. J Orthop Res 24(7):1489鈥?498 CrossRef
    39. Qiu S, Rao DS, Palnitkar S, Parfitt AM (2010) Dependence of bone yield (volume of bone formed per unit of cement surface area) on resorption cavity size during osteonal remodeling in human rib: implications for osteoblast function and the pathogenesis of age-related bone loss. J Bone Miner Res 25(2):423鈥?30 CrossRef
    40. Vashishth D, Koontz J, Qiu SJ, Lundin-Cannon D, Yeni YN, Schaffler MB, Fyhrie DP (2000) In vivo diffuse damage in human vertebral trabecular bone. Bone 26(2):147鈥?52 8756-3282(99)00253-7" target="_blank" title="It opens in new window">CrossRef
    41. Karim L, Tang S, Sroga G, Vashishth D (2013) Differences in non-enzymatic glycation and collagen crosslinks between human cortical and cancellous bone. Osteoporos Int 24(9):2441鈥?447 8-013-2319-4" target="_blank" title="It opens in new window">CrossRef
    42. Odetti P, Rossi S, Monacelli F, Poggi A, Cirnigliaro M, Federici M, Federici A (2005) Advanced glycation end products and bone loss during aging. Ann N Y Acad Sci 1043(1):710鈥?17 82" target="_blank" title="It opens in new window">CrossRef
    43. Diab T, Condon KW, Burr DB, Vashishth D (2006) Age-related change in the damage morphology of human cortical bone and its role in bone fragility. Bone 38(3):427鈥?31 CrossRef
    44. Schaffler MB, Choi K, Milgrom C (1995) Aging and matrix microdamage accumulation in human compact bone. Bone 17(6):521鈥?25 8756-3282(95)00370-3" target="_blank" title="It opens in new window">CrossRef
    45. Norman TL, Wang Z (1997) Microdamage of human cortical bone: Incidence and morphology in long bones. Bone 20(4):375鈥?79 8756-3282(97)00004-5" target="_blank" title="It opens in new window">CrossRef
    46. Arlot ME, Burt-Pichat B, Roux J-P, Vashishth D, Bouxsein ML, Delmas PD (2008) Microarchitecture influences microdamage accumulation in human vertebral trabecular bone. J Bone Miner Res 23(10):1613鈥?618 80517" target="_blank" title="It opens in new window">CrossRef
  • 刊物类别:Medicine
  • 刊物主题:Medicine & Public Health
    Orthopedics
    Gynecology
    Endocrinology
    Rheumatology
  • 出版者:Springer London
  • ISSN:1433-2965
文摘
Summary To better understand the association between different components of bone quality, we investigated the relationship among in vivo generated non-enzymatic glycation, resorption, and microdamage. The results showed negative correlation between advanced glycation end-products (AGEs) and resorption independent of age highlighting the interaction between these parameters that may lead to bone fragility. Introduction Changes in the quality of bone material contribute significantly to bone fragility. In order to establish a better understanding of the interaction of the different components of bone quality and their influence on bone fragility, we investigated the relationship between non-enzymatic glycation, resorption, and microdamage generated in vivo in cortical bone using bone specimens from the same donors. Methods Total fluorescent advanced glycation end-products (AGEs) were measured in 96 human cortical bone samples from 83 donors. Resorption pit density, average resorption pit area, and percent resorption area were quantified in samples from 48 common donors with AGE measurements. Linear microcrack density and diffuse damage were measured in 21 common donors with AGE and resorption measurements. Correlation analyses were performed between all measured variables to establish the relationships among them and their variation with age. Results We found that average resorption pit area and percent resorption area decreased with increasing AGEs independently of age. Resorption pit density and percent resorption area demonstrated negative age-adjusted correlation with diffuse damage. Furthermore, average resorption pit area, resorption pit density, and percent resorption area were found to decrease significantly with age. Conclusions The current study demonstrated the in vivo interrelationship between the organic constituents, remodeling, and damage formation in cortical bone. In addition to the age-related reduction in resorption, there is a negative correlation between AGEs and resorption independent of age. This inverse relationship indicates that AGEs alter the resorption process and/or accumulate in the tissue as a result of reduced resorption and may lead to bone fragility by adversely affecting fracture resistance through altered bone matrix properties.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700